Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03034057Phase 4Completed
Phase 4, open-label, single-arm trial of dmpa-sc in contraception, sponsored by Pfizer. Primary endpoint: Percentage of Successful Self-Injections Performed of All Attempts at Home on Schedule at 1 year. Started Aug 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03034057.